Home Human papilloma virus (HPV) molecular diagnostics
Article
Licensed
Unlicensed Requires Authentication

Human papilloma virus (HPV) molecular diagnostics

  • Christos Kroupis and Nikolaos Vourlidis
Published/Copyright: August 30, 2011

Abstract

Human Papilloma Virus (HPV) is becoming a menace worldwide, especially to the developing world, due to its involvement in a variety of malignancies, with cervical cancer being the most important and prevalent. There are many HPV types; HPV 16/18 are the most carcinogenic but few others are also characterized as high-risk (HR). They can cause a variety of low- or high-grade cellular abnormalities, most frequently detected in a routine Pap test. Most infections clear within 2 years, however, a minority persists and potentially could progress to cervical cancer. Molecular tests detecting HPV DNA, RNA or proteins are now being available either commercially or in-house developed. DNA detection is nowadays an established tool for diagnosis and monitoring of HPV-related disease, however, there is lack of a reference method and standardization with reference materials. The various available test formats create confusion on which molecular test to choose and what are its limitations. Therefore, the need for lab accreditation and participation in proficiency testing has to be stressed. Novel HPV biomarkers (RNA, protein etc.) are now intensively examined for their inclusion as adjunct tools. Recently, developed prophylactic vaccines for HPV 16/18 have already proven safe and efficient and raise high expectations for the complete eradication of these types in the future.


Corresponding author: Christos Kroupis, MSc, PhD, Asst. Prof. of Clinical Biochemistry and Molecular Diagnostics, Department of Clinical Biochemistry, Attikon University Hospital, University of Athens Medical School, 1 Rimini Street, Haidari 12462, Greece[ep Phone: +30-210-5831919, Fax: +30-210-6547748,

Received: 2011-1-30
Accepted: 2011-7-27
Published Online: 2011-08-30
Published in Print: 2011-11-01

©2011 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Editorial
  2. Thank you, indeed!
  3. Reviews
  4. Glomerular filtration rate estimation: performance of serum cystatin C-based prediction equations
  5. Oxidative stress and diabetes mellitus
  6. Human papilloma virus (HPV) molecular diagnostics
  7. Opinion Papers
  8. Urine immunofixation electrophoresis remains important and is complementary to serum free light chain
  9. Permissible performance limits of regression analyses in method comparisons
  10. General Clinical Chemistry and Laboratory Medicine
  11. The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease
  12. Relationship between bilirubin and C-reactive protein
  13. Status of serum-calcium and -albumin measurement in Argentina assessed in 300 representative laboratories with 20 fresh frozen single donation sera
  14. Practical application of Sigma Metrics QC procedures in clinical chemistry
  15. High-throughput analysis of testosterone in serum samples by on-line solid phase extraction liquid chromatography-tandem mass spectrometry
  16. Monitoring of mycophenolic acid and kidney function during combined immunosuppressive therapy
  17. Phenotype of Gc-globulin influences the macrophage activating factor (MAF) levels in serum
  18. Combination of cellular population data and CytoDiff™ analyses for the diagnosis of lymphocytosis
  19. Eosinophiluria is common among patients after ileal conduit surgery
  20. Soluble urokinase plasminogen activator receptor (suPAR) levels in healthy pregnancy and preeclampsia
  21. Uptake of cobalamin and markers of cobalamin status: a longitudinal study of healthy pregnant women
  22. Vitamin B12 absorption judged by measurement of holotranscobalamin, active vitamin B12: evaluation of a commercially available EIA kit
  23. Salivary markers of oxidative stress and Salivette collection systems
  24. Infectious Diseases
  25. Development of a microwell adapted immunoblot system with recombinant antigens for distinguishing human herpesvirus (HHV)6A and HHV6B and detection of human cytomegalovirus
  26. Cardiovascular Disease
  27. High-sensitive troponin T in chronic heart failure correlates with severity of symptoms, left ventricular dysfunction and prognosis independently from N-terminal pro-b-type natriuretic peptide
  28. Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort
  29. Letters to the Editor
  30. Iron deficiency prevalence is increased among Helicobacter pylori infected Brazilian patients
  31. Helicobacter pylori infection and iron deficiency in a group of Brazilian patients
  32. Multiplex protein assay performance/evaluation and the requirement for precision and correlation to clinical assays
  33. Functional assay or antigen test for protein C and protein S in ischemic stroke: which shows the greatest change?
Downloaded on 29.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm.2011.685/html
Scroll to top button